Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2020

Employee Benefit and Share-based Payment Arrangement, Noncash Expense [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity

Share option activity during the years indicated is as follows:

	Number of Shares	Weighted-Average Exercise Price Per Share
Balance at December 31, 2018	118,400	$	7.44
Exercised	(84,400)	7.24
Balance at December 31, 2019	34,000	7.95
Exercised	(34,000)	7.95
Balance at December 31, 2020	—	$	—

Schedule of Nonvested Share Activity

Non-vested share activity for the years ended December 31, 2020 and 2019, is as follows:

	Number of Shares	Weighted-Average Grant-Date Fair Value Per Share
Balance at December 31, 2018	3,455,077	$	7.34
Granted	829,581	5.97
Vested	(151,447)	5.06
Forfeited	(1,191,799)	6.76
Balance at December 31, 2019	2,941,412	7.30
Granted	709,250	7.77
Vested	(613,504)	8.80
Forfeited	(332,429)	5.30
Balance at December 31, 2020	2,704,729	$	7.27

Schedule of Share-based Compensation, Activity

During 2020 and 2019, the Company granted common shares to certain employees and trustees as follows:

	2020	2019
Performance Shares(1)
Shares issued:
Index	232,993	276,063
Peer	232,987	276,058
Grant date fair value per share:(2)
Index	$6.59	$5.05
Peer	$5.97	$4.67
Non-Vested Common Shares:(3)
Shares issued	243,270	277,460
Grant date fair value	$2,581	$2,270

(1)     The shares vest based on the Company's total shareholder return growth after a three-year measurement period relative to an index and a group of Company peers. Dividends will not be paid on these grants until earned. Once the performance criteria are met and the actual number of shares earned is determined, such shares vest immediately. During 2020, 122,779 of the 452,737 performance shares issued in 2017 vested. During 2019, 713,044 of the 808,929 performance shares issued in 2016 vested.

(2)    The fair value of grants was determined at the grant date using a Monte Carlo simulation model.

(3)    The shares vest ratably over a three-year service period